On behalf of Peter Razos, our Head of Science, we would like to invite you to this year’s Science Colloquium.
Date: Wednesday 23 August
Time: 6.00pm for a 6.30pm start
Guest Speakers: Dr Marco Herold and Dr Matthew Belousoff
Venue: South Room (Level 2) ‐ Peter Crawley Centre for the Arts, Charles Street, Kew
The evening will include drinks, canapés and a three course dinner.
To book your ticket, please visit trybooking.com/289867
Online ticket bookings close on Friday 18 August.
Dr Marco Herold
Molecular Genetics of Cancer Division at the Walter & Eliza Hall Institute of Medical Research
Topic: Overview of CRISPR/Cas9 technology – and its potential use in the development of groundbreaking cancer therapies.
Dr Herold is a Laboratory Head in the Molecular Genetics of Cancer Division at Walter & Eliza Hall Institute (WEHI). He is an expert in using CRISPR/Cas9 genome editing technology and has brought this powerful genome engineering to WEHI, establishing the new Genome Editing Laboratory. During his PhD and first postdoctoral studies at the University of Würzburg (Germany) he addressed key questions in cell death and cancer.
Dr Herold will be discussing his own work at WEHI on white blood cells including validation of potential novel drug targets and the importance of CRISPR/Cas9 in the development of ground breaking treatments for diseases such as cancer.
Click here to read more about Dr Marco Herold.
Dr Matthew Belousoff
NHRMC Fellow in the School of Microbiology at Monash University
Topic: What molecular changes transform a bacterium into a ‘Superbug’ – and how we can use this research to conquer antibiotic resistance?
Dr Belousoff is an NHMRC fellow in the laboratory of Professor Trevor Lithgow. He completed his Ph.D. in chemistry at Monash University and went onto post‐doctoral studies in the field of structural biology.
His research interests lie in understanding the structure and function of biomolecules. By understanding the molecular changes which transform a bacteria into a ‘superbug’ Dr Belousoff is working towards designs to make the next generation of antibiotics to permanently overcome the problem of antibiotic resistance.
Click here to read more about Dr Matthew Belousoff